We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.44B
AUM Growth
-$465M
Cap. Flow
-$442M
Cap. Flow %
-30.7%
Top 10 Hldgs %
11.9%
Holding
1,595
New
313
Increased
337
Reduced
470
Closed
413

Top Buys

Rank Stock Value
1
CEG icon
Constellation Energy
CEG
+$6.48M
2
AMK
AssetMark Financial Holdings, Inc.
AMK
+$6.21M
3
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$6.05M
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$5.93M
5
FTRE icon
Fortrea Holdings
FTRE
+$5.34M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$16.5M
2
NVDA icon
NVIDIA
NVDA
+$13.1M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$9.16M
4
VIPS icon
Vipshop
VIPS
+$8.72M
5
CSTR
CapStar Financial Holdings, Inc
CSTR
+$8.17M

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Healthcare 10.93%
3 Consumer Discretionary 9.87%
4 Industrials 9.31%
5 Financials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDRX icon
1076
GoodRx Holdings
GDRX
$1.26B
$127K 0.01%
16,277
+3,701
+29% +$27.4K
INGN icon
1077
Inogen
INGN
$164M
$126K 0.01%
15,460
-1,227
-7% -$9.5K
AEHR icon
1078
Aehr Test Systems
AEHR
$3.36B
$123K 0.01%
11,000
-11,000
-50% -$128K
MRAM icon
1079
Everspin Technologies
MRAM
$405M
$122K 0.01%
20,361
-19,912
-49% -$132K
TALK icon
1080
Talkspace
TALK
$874M
$121K 0.01%
52,700
-4,500
-8% -$12.9K
WEST icon
1081
Westrock Coffee
WEST
$803M
$120K 0.01%
+11,686
New +$120K
OI icon
1082
O-I Glass
OI
$1.08B
$120K 0.01%
10,739
-22,402
-68% -$303K
RXRX icon
1083
Recursion Pharmaceuticals
RXRX
$1.73B
$118K 0.01%
+15,794
New +$138K
ASLE icon
1084
AerSale
ASLE
$279M
$117K 0.01%
16,942
+3,057
+22% +$21.9K
HCAT icon
1085
Health Catalyst
HCAT
$128M
$116K 0.01%
18,227
-54,608
-75% -$351K
LSEA
1086
DELISTED
Landsea Homes
LSEA
$116K 0.01%
+12,600
New +$134K
ABOS icon
1087
Acumen Pharmaceuticals
ABOS
$176M
$112K 0.01%
46,410
+9,410
+25% +$30K
CHGG icon
1088
Chegg
CHGG
$102M
$111K 0.01%
+35,034
New +$174K
DSGN icon
1089
Design Therapeutics
DSGN
$876M
$110K 0.01%
32,956
-15,644
-32% -$61K
MEI icon
1090
Methode Electronics
MEI
$592M
$109K 0.01%
+10,525
New +$121K
MUFG icon
1091
Mitsubishi UFJ Financial
MUFG
$254B
$108K 0.01%
10,036
– –
DNMR
1092
DELISTED
Danimer Scientific, Inc.
DNMR
$108K 0.01%
4,462
– –
NUVB icon
1093
Nuvation Bio
NUVB
$2.32B
$106K 0.01%
36,440
-12,760
-26% -$38.9K
EFXT
1094
Enerflex
EFXT
$2.44B
$106K 0.01%
19,656
-6,906
-26% -$37.5K
ACEL icon
1095
Accel Entertainment
ACEL
$987M
$105K 0.01%
+10,235
New +$109K
VIR icon
1096
Vir Biotechnology
VIR
$1.49B
$104K 0.01%
11,654
-2,524
-18% -$24.2K
LTRX icon
1097
Lantronix
LTRX
$266M
$104K 0.01%
29,166
+6,800
+30% +$24.4K
LUNG icon
1098
Pulmonx
LUNG
$87.6M
$103K 0.01%
16,200
+4,000
+33% +$30.8K
VNDA icon
1099
Vanda Pharmaceuticals
VNDA
$302M
$99.5K 0.01%
17,603
-21,297
-55% -$110K
ASTL icon
1100
Algoma Steel
ASTL
$431M
$98.7K 0.01%
14,185
+3,685
+35% +$28.4K
42 43
44
45 46

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Prelude Capital Management held 1,595 positions worth $1.44B, down 24% from $1.91B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $442M in Q2 2024, closing 413 positions and reducing 470 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Constellation Energy worth $6.37M.

  • Prelude Capital Management's largest Q2 2024 buy was Constellation Energy: 31,786 shares worth $6.37M.
  • Prelude Capital Management added most to Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024, an estimated $6.05M increase.
  • Prelude Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $13.1M.
  • Prelude Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $16.5M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.44B portfolio in Q2 2024.
  • Prelude Capital Management opened 313 new positions and closed 413 in Q2 2024.
  • Prelude Capital Management's portfolio value fell 24% quarter-over-quarter to $1.44B.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.